🇺🇸 FDA
Patent

US 6461870

13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control

expired A61KA61K51/1206

Quick answer

US patent 6461870 (13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control) held by Isotechnika, Inc. expires Mon Oct 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Isotechnika, Inc.
Grant date
Tue Oct 08 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K51/1206